Results for tag: "Prothrombin Inhibitor"

The Prothrombin Inhibitor market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Prothrombin Inhibitors are anticoagulants, which are used to prevent and treat blood clots. These drugs are used to treat a variety of conditions, including deep vein thrombosis, pulmonary embolism, and atrial fibrillation. They are also used to prevent stroke in patients with atrial fibrillation. Prothrombin Inhibitors are typically administered orally or intravenously. The Prothrombin Inhibitor market is highly competitive, with a number of companies offering products. Some of the major players in the market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Boehringer Ingelheim. Show Less Read more